Ratio Review: Analyzing EyePoint Pharmaceuticals Inc (EYPT)’s Price-to-Cash and Price-to-Free Cash Flow

Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.

After finishing at $7.94 in the prior trading day, EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) closed at $7.46, down -6.05%. In other words, the price has decreased by -$6.05 from its previous closing price. On the day, 0.77 million shares were traded. EYPT stock price reached its highest trading level at $8.07 during the session, while it also had its lowest trading level at $7.45.

Ratios:

Our goal is to gain a better understanding of EYPT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.45 and its Current Ratio is at 5.50. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.10.

On August 28, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $15.

On January 22, 2024, JP Morgan started tracking the stock assigning a Overweight rating and target price of $35.JP Morgan initiated its Overweight rating on January 22, 2024, with a $35 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 23 ’24 when ANTHONY P. ADAMIS bought 67,100 shares for $10.04 per share.

David R. Guyer bought 36,975 shares of EYPT for $329,817 on Oct 14 ’24. On Aug 20 ’24, another insider, DICICCO WENDY F, who serves as the Director of the company, bought 2,567 shares for $7.79 each. As a result, the insider paid 19,997 and bolstered with 9,967 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EYPT now has a Market Capitalization of 509152448 and an Enterprise Value of 278469696. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.47 while its Price-to-Book (P/B) ratio in mrq is 1.83. Its current Enterprise Value per Revenue stands at 6.092 whereas that against EBITDA is -2.43.

Stock Price History:

Over the past 52 weeks, EYPT has reached a high of $30.99, while it has fallen to a 52-week low of $7.40. The 50-Day Moving Average of the stock is -23.87%, while the 200-Day Moving Average is calculated to be -38.32%.

Shares Statistics:

The stock has traded on average 864.96K shares per day over the past 3-months and 880110 shares per day over the last 10 days, according to various share statistics. A total of 53.52M shares are outstanding, with a floating share count of 48.60M. Insiders hold about 9.19% of the company’s shares, while institutions hold 104.23% stake in the company. Shares short for EYPT as of 1732838400 were 9246846 with a Short Ratio of 10.69, compared to 1730332800 on 9680960. Therefore, it implies a Short% of Shares Outstanding of 9246846 and a Short% of Float of 15.310000000000002.

Most Popular